LONDON - The European Commission has authorized the use of Vocabria and Rekambys, a long-acting injectable regimen, for adolescents living with HIV-1, ViiV Healthcare, majority-owned by GSK (NYSE: GSK ...
The Trump administration has issued a waiver to ensure uninterrupted HIV treatment for 20 million people in 55 countries, despite a 90-day freeze on US foreign aidGlobal health leaders, including ...